Aurelia Bank
Credit Risk Console
dashboard
Overview
warning
Watchlist
stacked_line_chart
Stress testing
Reporting date 31 Mar 2026
Quarter 2026-Q1
All amounts in EUR unless stated
Overview
/
Healthcare
Healthcare
3 obligors in the wholesale book
donut_large
Share 9.0%
Share
Exposure at default
Share
9.0%
Utilisation
88.0%
Exposure at default
€284.9m
Committed limit
€310.5m
Drawn
€273.2m
Undrawn
€37.3m
Expected loss
€2.3m
Risk-weighted assets
€314.8m
Weighted average PD
1.78%
Weighted average LGD
40.9%
Facilities
6
No data to display
Expected loss · Risk-weighted assets
#
Counterparties
3 obligors in the wholesale book
Counterparty
Country
Rating
PD
LGD
sorted descending
EAD
Expected loss
RWA
Utilisation
Corvina Pharma SA
Spain
B · 6
3.46%
46%
€106.8m
€1.7m
€185.5m
85%
Medistar Clinics Ltd
United Kingdom
BB · 5
1.22%
42%
€103.2m
€527k
€102.7m
92%
Silvan Care Holdings
Germany
A · 3
0.15%
32%
€74.8m
€36.6k
€26.7m
87%
1–3 of 3
Rows per page:
arrow_drop_down
check
10
25
All
first_page
chevron_left
chevron_right
last_page